Newman Ferrara LLP Announces Investigation of Conmed Health Management, Inc.

NEW YORK--(BUSINESS WIRE)--

Newman Ferrara LLP (www.nfllp.com) has begun an investigation into potential claims against the board of directors of Conmed Health Management, Inc. (“Conmed” or the Company) (NYSE: CONM), a leading provider of correctional facility healthcare services to county and municipal detention centers, concerning the merger agreement between Conmed and Correct Care Solutions (“CCS”).

On July 16, 2012, Conmed announced that it had entered into a definitive agreement to be acquired by CCS in a transaction valued at approximately $59 million. Under the agreement, Conmed shareholders will receive $3.95 in cash per share of Conmed common stock held. Upon consummation of the proposed transaction, Conmed will become an operating subsidiary of CCS and maintain its executive team and headquarters in Hanover, Maryland. Pursuant to the agreement, a cash tender offer is expected to commence on or before July 30, 2012. The proposed transaction is expected to close in the third quarter of 2012, subject to the satisfaction of a number of closing conditions, including that the holders of 90% of the outstanding shares of Conmed tender, and do not withdraw, their shares of Conmed stock prior to the expiration of the tender offer.

Newman Ferrara LLP's investigation concerns whether the Conmed board of directors is fulfilling its fiduciary duties to act in the best interests of Conmed's shareholders and to take all necessary steps to ensure that Conmed's shareholders receive the maximum value readily available for their shares of Conmed stock and are provided with all material information to make an informed decision on whether to tender their shares.

Concerned investors are encouraged to contact Newman Ferrara attorney Roy Shimon at (212) 619-5400 or rshimon@nfllp.com to discuss this investigation, their rights, or potential remedies.

Newman Ferrara maintains a multifaceted practice based in New York City with attorneys specializing in complex commercial and multi-party litigation with an emphasis on securities, ERISA, consumer fraud, products liability, civil rights and real estate. For more information, please visit the firm website at www.nfllp.com.